Mendus to participate in several investor and industry conferences in November and to host investor webcast and lunch on November 9
Press release Stockholm, Sweden, October 26, 2023 Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that...